Renjie Zhu
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
High-PepBinder: A pLM-Guided Latent Diffusion Framework for Affinity-Aware Target-Specific Peptide Design.
Journal: Journal of chemical information and modeling
Published: April 04, 2026
HFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion.
Journal: Chemical science
Published: March 31, 2026
Efficacy of Acupuncture Treatment in the Treatment of Female Myofascial Pelvic Pain Syndrome: A Protocol for a Dual-Center Randomized Controlled Trial.
Journal: Journal of pain research
Published: March 27, 2026
Superior NO2 sensing via semiconductor-metal transition in undoped Hf2CO2 MXene: doping-mediated trade-offs between surface reactivity and electronic properties.
Journal: Physical chemistry chemical physics : PCCP
Published: August 29, 2025
Coarse-Grained Simulation of Persistence Length and Twisting Dynamics of Micrometer-Scale Microtubules.
Journal: The journal of physical chemistry letters
Published: July 11, 2025
Accelerating the exploration of material space for hydride double perovskite superconductors under ambient pressure through machine learning.
Journal: The Journal of chemical physics
Published: March 03, 2025
Clinical observation on warming needle moxibustion combined with rehabilitation techniques in the treatment of anterior disc displacement without reduction.
Journal: Clinical oral investigations
Published: June 14, 2024
Laxative effect of Wenyang Yiqi Decoction on loperamide-induced astriction model mice.
Journal: Annals of translational medicine
Published: December 09, 2022
CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression.
Journal: Cancers
Published: August 23, 2022
CircMMP1 promotes colorectal cancer growth and metastasis by sponging miR-1238 and upregulating MMP family expression.
Journal: Annals of translational medicine
Published: July 02, 2021
MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer.
Journal: Current cancer drug targets
Published: January 07, 2021
Last Updated: 09/26/2026